Insights

Reset
ADVI Angle Vertical

Featured

Insights

ADVI Expert Caitlin Sheetz Discusses IRA Implications at ISPOR

View Article

ADVI insights

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CMS Releases Medicaid Drug Rebate Program Final Rule

Insights,

| Allison Schneider - Senior Manager

ADVI Analysis: MedPAC September 2024 Meeting

Insights,

| Irina Yermilov, MD, MPH, MS - Senior Director

PHAR Partners Present at the National Bleeding Disorders Conference

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CMS Issues MFPs for the First 10 Drugs Selected for Government Negotiation
View All

Case Studies

Case Study: Strengthening Positioning for IRA Drug Price Negotiation

Case Study: Medicare Utilization and Cost Trends for CAR-T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma

Case Study: Parkinson’s Cell and Gene Therapy: Commercialization Strategy Workshop

Case Study: CMMI Engagement on CGT Model
View All

Events

Events Meet with ADVI Experts at AVBCC 2024
Events ADVI Health Experts at AMCP Nexus 2024
Events Alicia Silver Speaks at the American Society of Gene and Cell Therapy Policy Summit
Events Meet with ADVI Experts at Meeting on the Mesa
Events Lauren Feldman To Present At 16th Annual Next Generation Dx Summit
Events ADVI Senior Advisor Matt Salo at MAHP 2024
View All

News

In The News Lindsay Bealor Greenleaf Interviewed by Pharmacy Times on IRA Drug Pricing Announcement
In The News Lindsay Bealor Greenleaf Discusses IRA Negotiated Drug Prices with Managed Healthcare Executive
In The News ADVI Health Acquires Partnership for Health Analytic Research (PHAR)
In The News Lindsay Bealor Greenleaf Shares IRA Insights In Axios
In The News Chris Wittwer featured in the Kansas City Business Journal
In The News ADVI Health Welcomes Chris Wittwer as Chief Financial Officer
View All

Videos

Evolving Healthcare Landscape: Cell and Gene Therapy, Part 1

Evolving Healthcare Landscape: Reimbursement

PDAB Considerations and Potential Market Access Impacts

Evolving Healthcare Landscape: Cell and Gene
View All